Akros U.S. AI Software TOP4 Plus Index
Concentrated exposure to U.S. AI software leaders across platforms and verticals.
Sentiment Summary
Recent Events
First quarter 2026 earnings results and conference call, with a market reaction of at least 5% possible based on previous volatility, scheduled.
First quarter 2026 financial results are scheduled to be released after the U.S. market closes. High importance is estimated due to historical price impact of earnings, scheduled
Fastly Q1 2026 earnings release scheduled. High importance as earnings reports for volatile tech stocks often lead to significant price movements.
Tempus AI is expected to release its Q1 2026 earnings on May 5, 2026. Analysts forecast an EPS of -$0.21 to -$0.30, with the market pricing in a potential post-earnings stock price move of over 15% scheduled.
Palantir announced on April 13, 2026, that its first-quarter 2026 financial results will be released on May 4, 2026. This announcement is estimated to cause a price impact of at least 5%, scheduled.
ServiceNow is scheduled to release its financial results for the first quarter of 2026 after the market closes on April 22, 2026; high importance is estimated due to the significant price impact typically associated with quarterly earnings, scheduled.
Fastly announced a partnership with VSTECS Phils., Inc. to serve as its first distributor in the Philippines. The stock jumped 8.5% following the announcement.
Oracle announced a partnership with AWS on April 16, 2026, to provide direct connections between OCI and AWS, enhancing multicloud capabilities. This strategic partnership is estimated to result in a price impact of approximately 5%, expected.
A securities class action lawsuit filing against Snowflake is scheduled for April 16, 2026, for investors who purchased stock between June 27, 2023, and February 28, 2024; a 1-2% impact is estimated as initial litigation typically has limited immediate market effect; expected.
Salesforce to announce 'Headless 360' platform and 'AgentExchange' at TDX 2026 on April 15, 2026; a ~5% price impact is scheduled.
On April 15, 2026, Tempus announced a collaboration with Predicta Biosciences to launch GenoPredicta, a whole-genome sequencing assay for hematologic cancers and measurable residual disease (MRD) monitoring.
On April 13, 2026, Oracle announced an expanded partnership to procure up to 2.8 GW of power from Bloom Energy for AI data centers. This expansion is estimated to cause a stock surge with a price impact of at least 5%, expected.
On April 13, 2026, Tempus launched an automated 'Active Follow-Up' service to provide updated therapy guidance for oncology providers as clinical guidelines change, without requiring new patient samples.